Karcioglu 2013.
Study characteristics | ||
Methods | Randomised, double‐blind, placebo control | |
Participants | N = 40, gender of participants not presented in demographic data | |
Interventions | Ketamine 1 mg/kg bolus IV at anaesthesia induction + 25 mcg/kg/min IV infusion until the end of surgery | |
Outcomes | Pain intensity (VAS) reported at PACU discharge and at 24 h postoperatively. Analgesic consumption reported as proportion (%) of participants receiving analgesics. AEs | |
Surgery type | Laparoscopic cholecystectomy | |
Group numbers after end of study (treatment/control) | 17/20 | |
Age of patient population (treatment/control) | 38.6 ± 11.7 43.4 ± 12.1 |
|
Notes | No mention of sponsorship or funding. The authors declare no conflicts of interest | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Computer‐generated random sequence |
Allocation concealment (selection bias) | Unclear risk | Allocation concealment method not described |
Blinding of participants and personnel (performance bias) All outcomes | Low risk | Blinded personnel |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Not reported |
Incomplete outcome data (attrition bias) All outcomes | Low risk | 8% was withdrawn |
Selective reporting (reporting bias) | Low risk | Predefined outcomes reported (three participants withdrawn from the ketamine group because of hypertension) |
Size | High risk | 17 and 20 participants per treatment arm |